Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Total Liabilities (2013 - 2026)

Xencor (XNCR) posted quarterly Total Liabilities of $221.2 million for Q1 2026, down 16.47% year-over-year from $264.8 million in Q1 2025, and down 7.79% quarter-over-quarter from $239.9 million in Q4 2025.

Analysis

Xencor (XNCR) Total Liabilities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Total Liabilities for 14 consecutive years, with $221.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Liabilities fell 16.47% year-over-year to $221.2 million; the TTM figure through Mar 2026 stood at $221.2 million (down 16.47% YoY), while the FY2025 annual figure was $239.9 million, down 13.68% from the prior year.
  • Total Liabilities eased to $221.2 million in Q1 2026 per XNCR's latest filing, from $239.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $303.0 million in Q4 2023 and bottomed at $94.9 million in Q1 2022.
  • Historically, Total Liabilities has averaged $203.3 million across 5 years, with a median of $239.9 million in 2025.
  • Annual changes were most pronounced in 2024 — Total Liabilities soared 194.13% — and 2025, when it dropped 17.17%.
  • Xencor's Total Liabilities stood at $118.8 million in 2022, then jumped by 155.16% to $303.0 million in 2023, then dropped by 8.29% to $277.9 million in 2024, then slipped by 13.68% to $239.9 million in 2025, then declined by 7.79% to $221.2 million in 2026.
  • Business Quant data shows XNCR's Total Liabilities at $221.2 million in Q1 2026, $239.9 million in Q4 2025, and $243.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Xencor 2.02 Bn 1.65 Bn - 221.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 221.73 Mn
Mar 31, 2026 221.21 Mn
Dec 31, 2025 239.91 Mn
Sep 30, 2025 243.50 Mn
Jun 30, 2025 259.07 Mn
Mar 31, 2025 264.82 Mn
Dec 31, 2024 277.92 Mn
Sep 30, 2024 293.98 Mn
Jun 30, 2024 291.91 Mn
Mar 31, 2024 297.12 Mn
Dec 31, 2023 303.05 Mn
Sep 30, 2023 109.42 Mn
Jun 30, 2023 99.25 Mn
Mar 31, 2023 119.83 Mn
Dec 31, 2022 118.77 Mn
Sep 30, 2022 112.57 Mn
Jun 30, 2022 108.98 Mn
Mar 31, 2022 94.90 Mn
Dec 31, 2021 104.71 Mn
Sep 30, 2021 78.40 Mn